Logo image of RLX

RLX TECHNOLOGY INC-ADR (RLX) Stock Fundamental Analysis

NYSE:RLX - New York Stock Exchange, Inc. - US74969N1037 - ADR - Currency: USD

1.85  +0.01 (+0.54%)

After market: 1.85 0 (0%)

Fundamental Rating

5

Overall RLX gets a fundamental rating of 5 out of 10. We evaluated RLX against 8 industry peers in the Tobacco industry. RLX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. RLX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

RLX had positive earnings in the past year.
Of the past 5 years RLX 4 years were profitable.
RLX had a positive operating cash flow in 4 of the past 5 years.
RLX Yearly Net Income VS EBIT VS OCF VS FCFRLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

With a Return On Assets value of 3.38%, RLX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.53%, RLX is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
ROA 3.38%
ROE 3.53%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RLX Yearly ROA, ROE, ROICRLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 20.08%, RLX belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
RLX's Profit Margin has improved in the last couple of years.
RLX has a Gross Margin (26.43%) which is comparable to the rest of the industry.
RLX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 20.08%
GM 26.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-5.46%
PM growth 5Y45.5%
GM growth 3Y-15.04%
GM growth 5Y-6.75%
RLX Yearly Profit, Operating, Gross MarginsRLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

RLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for RLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RLX Yearly Shares OutstandingRLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 500M 1B
RLX Yearly Total Debt VS Total AssetsRLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

RLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.5%
RLX Yearly LT Debt VS Equity VS FCFRLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 14.38 indicates that RLX has no problem at all paying its short term obligations.
RLX's Current ratio of 14.38 is amongst the best of the industry. RLX outperforms 100.00% of its industry peers.
A Quick Ratio of 14.25 indicates that RLX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 14.25, RLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.38
Quick Ratio 14.25
RLX Yearly Current Assets VS Current LiabilitesRLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.36% over the past year.
The Earnings Per Share has been growing by 70.17% on average over the past years. This is a very strong growth
Looking at the last year, RLX shows a very strong growth in Revenue. The Revenue has grown by 73.26%.
The Revenue has been growing by 12.15% on average over the past years. This is quite good.
EPS 1Y (TTM)7.36%
EPS 3Y-33.26%
EPS 5Y70.17%
EPS Q2Q%-41.54%
Revenue 1Y (TTM)73.26%
Revenue growth 3Y-31.42%
Revenue growth 5Y12.15%
Sales Q2Q%56.3%

3.2 Future

RLX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.16% yearly.
The Revenue is expected to grow by 19.34% on average over the next years. This is quite good.
EPS Next Y14.39%
EPS Next 2Y15.35%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year19.51%
Revenue Next 2Y18.57%
Revenue Next 3Y19.34%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RLX Yearly Revenue VS EstimatesRLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
RLX Yearly EPS VS EstimatesRLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.50, the valuation of RLX can be described as rather expensive.
RLX's Price/Earnings is on the same level as the industry average.
RLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
The Price/Forward Earnings ratio is 16.49, which indicates a correct valuation of RLX.
75.00% of the companies in the same industry are more expensive than RLX, based on the Price/Forward Earnings ratio.
RLX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.5
Fwd PE 16.49
RLX Price Earnings VS Forward Price EarningsRLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RLX Per share dataRLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
RLX's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)0.26
EPS Next 2Y15.35%
EPS Next 3Y14.16%

More info and screens

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.43%, RLX is not a good candidate for dividend investing.
RLX's Dividend Yield is slightly below the industry average, which is at 3.99.
Compared to an average S&P500 Dividend Yield of 2.45, RLX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

RLX is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
RLX Yearly Dividends per shareRLX Yearly Dividends per shareYearly Dividends per share 2023 2024 0.01 0.01 0.02

5.3 Sustainability

DP0%
EPS Next 2Y15.35%
EPS Next 3Y14.16%
RLX Yearly Income VS Free CF VS DividendRLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

More info and screens

RLX TECHNOLOGY INC-ADR

NYSE:RLX (5/2/2025, 8:21:31 PM)

After market: 1.85 0 (0%)

1.85

+0.01 (+0.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)03-14 2025-03-14/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners25.9%
Inst Owner Change-0.34%
Ins Owners45.11%
Ins Owner ChangeN/A
Market Cap2.25B
Analysts77.5
Price Target3 (62.16%)
Short Float %11.29%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.47%
Min EPS beat(2)-5.94%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-4.58%
Min EPS beat(4)-9.79%
Max EPS beat(4)-0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.08%
Min Revenue beat(2)0.83%
Max Revenue beat(2)5.33%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)5.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.69%
Valuation
Industry RankSector Rank
PE 18.5
Fwd PE 16.49
P/S 5.96
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)0.1
EY5.41%
EPS(NY)0.11
Fwd EY6.06%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.31
BVpS1.77
TBVpS1.75
PEG (NY)1.29
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 3.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.08%
GM 26.43%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-5.46%
PM growth 5Y45.5%
GM growth 3Y-15.04%
GM growth 5Y-6.75%
F-ScoreN/A
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.38
Quick Ratio 14.25
Altman-Z N/A
F-ScoreN/A
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.36%
EPS 3Y-33.26%
EPS 5Y70.17%
EPS Q2Q%-41.54%
EPS Next Y14.39%
EPS Next 2Y15.35%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)73.26%
Revenue growth 3Y-31.42%
Revenue growth 5Y12.15%
Sales Q2Q%56.3%
Revenue Next Year19.51%
Revenue Next 2Y18.57%
Revenue Next 3Y19.34%
Revenue Next 5YN/A
EBIT growth 1Y78.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.93%
EBIT Next 3Y47.82%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A